Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.
Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…Uncovering Patient Perspectives on Parkinson’s Disease to Inform Individualized Care
Objective: To gather patient insights on the burden of Parkinson’s disease (PD), understand the level of patient involvement in treatment decision-making, and determine overall satisfaction…Surprising Somatotopy: Buccinator Dyskinesia (Orobuccal Popeye Sign) Induced by Subthalamic Brain Stimulation in Parkinson’s Disease
Objective: To describe a clinical case of buccinator movements evoked by subthalamic nucleus deep brain stimulation (STN-DBS) in a patient with advanced Parkinson's disease (PD)…The development of an electronic motor symptoms diary for Parkinson’s disease using qualitative patient insights
Objective: To develop an electronic version of the Hauser diary, commonly used in clinical trials to assess motor fluctuations and dyskinesia in patients with Parkinson’s…Study of Wearable Technology And Geo-Fencing Device for Quantification of Freezing of Gait And Sleep Pattern In Dystonia Patients In Gurugram City, India
Objective: The aim of study was to investigate the benefits of wearable devices (Amazfit GTS-3 watch ) and geo-fencing technology to monitor daily life routine…Pharmacological neuromodulation with intracerebroventricular administration of anaerobic dopamine for Parkinson’s disease
Objective: To assess the continuous intracerebroventricular (i.c.v.) of A-dopamine in patients with a telemetry-controlled intra-abdominal pump system connected to a subcutaneous catheter implanted through the…Measuring Motor Improvement with a Wearable Device in a Parkinson Disease Patient undergoing Subcutaneous Levodopa Carbidopa Infusion
Objective: To assess the feasibility of a wearable device for objective quantification of motor improvement in Parkinson's Disease (PD) patients undergoing a therapy from oral…Long-Term Safety and Efficacy of Foscarbidopa/Foslevodopa in Patients with Advanced Parkinson’s Disease: Results From an Ongoing Phase 3 Open-Label Extension with Up to 1 Year Follow-Up
Objective: Evaluate long-term safety and efficacy of foslevodopa/foscarbidopa (LDp/CDp) among people with advanced Parkinson’s disease (aPD). Background: As aPD progresses, erratic gastric emptying and pulsatile…Paroxysmal non-kinesigenic dyskinesia: atypical neurological presentation of Lyme neuroborreliosis
Objective: To describe unusaul case of paroxysmal non-kinesigenic dyskinesia due to Lyme neuroborreliosis in a elderly female patient. Background: Nervous system Lyme disease is common…Long-term Safety and Efficacy for Motor Fluctuations and Quality of Life With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Interim Results From an Ongoing Open Label Extension
Objective: Evaluate long-term motor symptom control and improvement in quality of life (QoL) with foslevodopa/foscarbidopa (LDp/CDp) compared with baseline (BL) values from the parent study…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 40
- Next Page »